Dysmorphic syndrome due to mucopolysaccharidosis type I

被引：0
|
作者：
Mounach, J. [1 ]
Abilkassem, R. [2 ]
Satte, A. [1 ]
Ouahmane, Y. [1 ]
Berri, M. Ait [1 ]
Agadr, A. [2 ]
Ouhabi, H. [1 ]
Zerhouni, A. [1 ]
机构：
[1] Hop Mil Instruct Mohammed V, Serv Neurophysiol, Rabat, Morocco
[2] Hop Mil Instruct Mohammed V, Serv Pediat, Rabat, Morocco
来源：
ARCHIVES DE PEDIATRIE | 2014年 / 21卷 / 04期
关键词：
ENZYME REPLACEMENT THERAPY;
D O I：
10.1016/j.arcped.2014.01.006
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：415 / 417
页数：3
相关论文
共 50 条
  • [41] Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management
    Clarke, Lorne A.
    Atherton, Andrea M.
    Burton, Barbara K.
    Day-Salvatore, Debra L.
    Kaplan, Paige
    Leslie, Nancy D.
    Scott, C. Ronald
    Stockton, David W.
    Thomas, Janet A.
    Muenzer, Joseph
    JOURNAL OF PEDIATRICS, 2017, 182 : 363 - 370
  • [42] Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies
    Palpant, Nathan J.
    Bedada, Fikru B.
    Peacock, Brandon
    Blazar, Bruce R.
    Metzger, Joseph M.
    Tolar, Jakub
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2011, 300 (01): : H356 - H365
  • [43] Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment
    Shapiro, Elsa G.
    Nestrasil, Igor
    Rudser, Kyle
    Delaney, Kathleen
    Kovac, Victor
    Ahmed, Alia
    Yund, Brianna
    Orchard, Paul J.
    Eisengart, Julie
    Niklason, Gregory R.
    Raiman, Julian
    Mamak, Eva
    Cowan, Morton J.
    Bailey-Olson, Mara
    Harmatz, Paul
    Shankar, Suma P.
    Cagle, Stephanie
    Ali, Nadia
    Steiner, Robert D.
    Wozniak, Jeffrey
    Lim, Kelvin O.
    Whitley, Chester B.
    MOLECULAR GENETICS AND METABOLISM, 2015, 116 (1-2) : 61 - 68
  • [44] Synergistic effects of resveratrol and enzyme replacement therapy in the Mucopolysaccharidosis type I
    Rintz, Estera
    Ziemian, Maja
    Kobus, Barbara
    Gaffke, Lidia
    Pierzynowska, Karolina
    Wegrzyn, Grzegorz
    BIOCHEMICAL PHARMACOLOGY, 2024, 229
  • [45] Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models
    Kingma, Sandra D. K.
    Wagemans, Tom
    IJlst, Lodewijk
    Wijburg, Frits A.
    van Vlies, Naomi
    JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (05) : 813 - 821
  • [46] Characterization of Surgical Procedures in Patients with Mucopolysaccharidosis Type I: Findings from the MPS I Registry
    Arn, Pamela
    Wraith, J. Edmond
    Underhill, Lisa
    JOURNAL OF PEDIATRICS, 2009, 154 (06) : 859 - 864
  • [47] Clinical Experiments in Patients with Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome)
    Er, Esra
    Canda, Ebru
    Ucar, Sema Kalkan
    Sozmen, Eser
    Coker, Mahmut
    JOURNAL OF PEDIATRIC RESEARCH, 2016, 3 (02) : 82 - 85
  • [48] Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I
    Laraway, Sarah
    Mercer, Jean
    Jameson, Elisabeth
    Ashworth, Jane
    Hensman, Pauline
    Jones, Simon A.
    JOURNAL OF PEDIATRICS, 2016, 178 : 219 - +
  • [49] Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs
    Simonaro, Calogera M.
    Tomatsu, Shunji
    Sikora, Tracy
    Kubaski, Francyne
    Frohbergh, Michael
    Guevara, Johana M.
    Wang, Raymond Y.
    Vera, Moin
    Kang, Jennifer L.
    Smith, Lachlan J.
    Schuchman, Edward H.
    Haskins, Mark E.
    PLOS ONE, 2016, 11 (04):
  • [50] Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report
    Muenzer, J
    Lamsa, JC
    Garcia, A
    Dacosta, J
    Garcia, J
    Treco, DA
    ACTA PAEDIATRICA, 2002, 91 : 98 - 99
12345